Skip to Content

GG 261 (Meclizine 25 mg)

Pill imprint GG 261 has been identified as Meclizine hydrochloride 25 mg.

Meclizine is used in the treatment of vertigo; nausea/vomiting; motion sickness and belongs to the drug class anticholinergic antiemetics. There is no proven risk in humans during pregnancy. Meclizine 25 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Meclizine hydrochloride 25 mg GG 261
Meclizine hydrochloride 25 mg GG 261
Meclizine hydrochloride
GG 261
25 mg
Elliptical / Oval
Rx and/or OTC
Drug Class:
Anticholinergic antiemetics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0163 McKesson Packaging Services
60429-0608 Golden State Medical Supply (repackager)
55289-0159 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.